Herpesviruses: Harmonious pathogens but relevant cofactors in other diseases?

Frontiers in Cellular and Infection Microbiology

Volumn 8, Issue MAY, 2018, Pages

  Sehrawat, Sharvan ^a   Kumar, Dhaneshwar ^a   Rouse, Barry T ^b  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH MOHALI   (India)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Cofactors; Coinfections; Disease outcome; Herpesviruses; Host pathogen interactions; Virome

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ACUTE HIV INFECTION; AGING; CANCER PATIENT; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE SEVERITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HOST; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LATENT PERIOD; MOLECULAR PATHOLOGY; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STRESS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REACTIVATION; ANIMAL; AUTOIMMUNE DISEASE; COMPLICATION; HERPES VIRUS INFECTION; HERPESVIRIDAE; HETEROLOGOUS IMMUNITY; HOST PARASITE INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALARIA; MIXED INFECTION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

ANIMALS; AUTOIMMUNE DISEASES; COINFECTION; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY, HETEROLOGOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALARIA;

EID: 85047525746     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2018.00177     Document Type: Review

References (218)

1. Abdollahpour, H., Appaswamy, G., Kotlarz, D., Diestelhorst, J., Beier, R., Schaffer, A. A., et al. (2012). The phenotype of human STK4 deficiency. Blood 119, 3450-3457. doi: 10.1182/blood-2011-09-378158
2. Ahn, K., Gruhler, A., Galocha, B., Jones, T. R., Wiertz, E. J. H., Ploegh, H. L., et al. (1997). The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6, 613-621. doi: 10.1016/S1074-7613(00)80349-0
3. Albrecht, M. A., DeLuca, N. A., Byrn, R. A., Schaffer, P. A., and Hammer, S. M. (1989). The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. J. Virol. 63, 1861-1868
4. Angelini, D. F., Serafini, B., Piras, E., Severa, M., Coccia, E. M., Rosicarelli, B., et al. (2013). Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog. 9:e1003220. doi: 10.1371/journal.ppat.1003220
5. Antinone, S. E., and Smith, G. A. (2010). Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis. J. Virol. 84, 1504-1512. doi: 10.1128/JVI.02029-09
6. Barel, M. T., Ressing, M., Pizzato, N., van Leeuwen, D., Le Bouteiller, P., Lenfant, F., et al. (2003). Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J. Immunol. 171, 6757-6765. doi: 10.4049/jimmunol.171.12.6757
7. Bartlett, J., Shao, J., Schechter, M., Balestre, E., and Myer, L. (2012). CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med. 9:e1001194. doi: 10.1371/journal.pmed.1001194
8. Barton, E. S., White, D. W., Cathelyn, J. S., Brett-McClellan, K. A., Engle, M., Diamond, M. S., et al. (2007). Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326-329. doi: 10.1038/nature05762
9. Bellare, P., and Ganem, D. (2009). Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6, 570-575. doi: 10.1016/j.chom.2009.11.008
10. Beral, P. (1991). AIDS-associated non-Hodgkin lymphoma. Lancet 337, 805-809. doi: 10.1016/0140-6736(91)92513-2
11. Birkenbach, M., Josefsen, K., Yalamanchili, R., Lenoir, G., and Kieff, E. (1993). Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67, 2209-2220
12. Biswas, S. C., and Greene, L. A. (2002). Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein bim and suppresses its proapoptotic activity by phosphorylation. J. Biol. Chem. 277, 49511-49516. doi: 10.1074/jbc. M208086200
13. Bloom, D. C., Giordani, N. V., and Kwiatkowski, D. L. (2010). Epigenetic regulation of latent HSV-1 gene expression. Biochim. Biophys. Acta 1799, 246-256. doi: 10.1016/j.bbagrm.2009.12.001
14. Boshoff, C., and Weiss, R. A. (2001). Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 517-534. doi: 10.1098/rstb.2000.0778
15. Buchbinder, S. P., Katz, M. H., Hessol, N. A., Liu, J. Y., O'Malley, P. M., Underwood, R., et al. (1992). Herpes zoster and human immunodeficiency virus infection. J. Infect. Dis. 166, 1153-1156
16. Campbell, T. M., McSharry, B. P., Steain, M., Slobedman, B., and Abendroth, A. (2015). Varicella-zoster virus and herpes simplex virus 1 differentially modulate NKG2D ligand expression during productive infection. J. Virol. 89, 7932-7943. doi: 10.1128/JVI.00292-15
17. Cantin, E. M., Hinton, D. R., Chen, J., and Openshaw, H. (1995). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69, 4898-4905
18. Casrouge, A., Zhang, S.-Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., et al. (2006). Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308-312. doi: 10.1126/science.1128346
19. Chêne, A., Donati, D., Guerreiro-Cacais, A. O., Levitsky, V., Chen, Q., Falk, K. I., et al. (2007). A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog. 3:e80. doi: 10.1371/journal.ppat.0030080
20. Chen, S. H., Kramer, M. F., Schaffer, P. A., and Coen, D. M. (1997). A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 71, 5878-5884
21. Cherpes, T. L., Melan, M. A., Kant, J. A., Cosentino, L. A., Meyn, L. A., and Hillier, S. L. (2005). Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin. Infect. Dis. 40, 1422-1428. doi: 10.1086/429622
22. Chien, Y., Meyer, C., and Bonneville, M. (2014). γδ T cells: first line of defense and beyond. Annu. Rev. Immunol. 32, 121-155. doi: 10.1146/annurev-immunol-032713-120216
23. Clute, S. C., Watkin, L. B., Cornberg, M., Naumov, Y. N., Sullivan, J. L., Luzuriaga, K., et al. (2005). Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J. Clin. Invest. 115, 3602-3612. doi: 10.1172/JCI25078
24. Coscoy, L. (2007). Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat. Rev. Immunol. 7, 391-401. doi: 10.1038/nri2076
25. Couzi, L., Pitard, V., Moreau, J.-F., Merville, P., and Déchanet-Merville, J. (2015). Direct and indirect effects of cytomegalovirus-induced T cells after kidney transplantation. Front. Immunol. 6, 3. doi: 10.3389/fimmu.2015.00003
26. Crandell, R. A., Mesfin, G. M., and Mock, R. E. (1982). Horizontal transmission of pseudorabies virus in cattle. Am. J. Vet. Res. 43, 326-328
27. Croft, N. P., Shannon-Lowe, C., Bell, A. I., Horst, D., Kremmer, E., Ressing, M. E., et al. (2009). Stage-specific inhibition of MHC class I Presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog. 5:e1000490. doi: 10.1371/journal.ppat.1000490
28. Crompton, P. D., Mircetic, M., Weiss, G., Baughman, A., Huang, C.-Y., Topham, D. J., et al. (2009). The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. J. Immunol. 182, 3318-3326. doi: 10.4049/jimmunol.0803596
29. Crozat, K., Hoebe, K., Ugolini, S., Hong, N. A., Janssen, E., Rutschmann, S., et al. (2007). Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J. Exp. Med. 204, 853-863. doi: 10.1084/jem.20062447
30. Depledge, D. P., Ouwendijk, W. J. D., Sadaoka, T., Braspenning, S. E., Mori, Y., Cohrs, R., et al. (2017). Newly identified varicella-zoster virus latency transcript inhibits viral replication. bioRxiv 174797. doi: 10.1101/174797
31. Deshpande, S., Zheng, M., Lee, S., Banerjee, K., Gangappa, S., Kumaraguru, U., et al. (2001). Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 167, 2902-2910. doi: 10.4049/jimmunol.167.5.2902
32. Des Jarlais, D. C., Arasteh, K., McKnight, C., Perlman, D. C., Feelemyer, J., Hagan, H., et al. (2014). HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York city. PLoS ONE 9:e87993. doi: 10.1371/journal.pone.0087993
33. Dowling, J. N., Saslow, A. R., Armstrong, J. A., and Ho, M. (1976). Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders. J. Infect. Dis. 133, 399-408. doi: 10.1093/infdis/133.4.399
34. Drobyski, W. R., Knox, K. K., Majewski, D., and Carrigan, D. R. (1994). Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N. Engl. J. Med. 330, 1356-1360. doi: 10.1056/NEJM199405123301905
35. Dropulic, L. K., and Cohen, J. I. (2011). Severe viral infections and primary immunodeficiencies. Clin. Infect. Dis. 53, 897-909. doi: 10.1093/cid/cir610
36. Du, T., Han, Z., Zhou, G., Roizman, B., and Roizman, B. (2015). Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation. Proc. Natl. Acad. Sci. U.S.A. 112, E49-E55. doi: 10.1073/pnas.1422657112
37. Dunne, P. J., Faint, J. M., Gudgeon, N. H., Fletcher, J. M., Plunkett, F. J., Vieira, M., et al. (2002). Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 100, 933-940. doi: 10.1182/blood-2002-01-0160
38. Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., et al. (2003). Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388-391. doi: 10.1038/ng1097
39. Epstein, M., Achong, B., and Barr, Y. (1964). Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 283, 702-703
40. Fickel, J., Richman, L. K., Montali, R., Schaftenaar, W., Göritz, F., Hildebrandt, T. B., et al. (2001). A variant of the endotheliotropic herpesvirus in Asian elephants (Elephas maximus) in European zoos. Vet. Microbiol. 82, 103-109. doi: 10.1016/S0378-1135(01)00363-7
41. Finkbeiner, S. (2000). CREB couples neurotrophin signals to survival messages. Neuron 25, 11-14. doi: 10.1016/S0896-6273(00)80866-1
42. Fitzgerald, P. A., Mendelsohn, M., and Lopez, C. (1985). Human natural killer cells limit replication of herpes simplex virus type 1 in vitro. J. Immunol. 134, 2666-2672
43. Frank, G. M., Lepisto, A. J., Freeman, M. L., Sheridan, B. S., Cherpes, T. L., and Hendricks, R. L. (2010). Early CD4+ T cell help prevents partial CD8+ T cell exhaustion and promotes maintenance of herpes simplex virus 1 latency. J. Immunol. 184, 277-286. doi: 10.4049/jimmunol.0902373
44. Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., and Hayes, R. J. (2006). Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20, 73-83. doi: 10.1097/01.aids.0000198081.09337.a7
45. Freeman, M. L., Lanzer, K. G., Cookenham, T., Peters, B., Sidney, J., Wu, T.-T., et al. (2010). Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J. Virol. 84, 2881-2892. doi: 10.1128/JVI.02229-09
46. Furman, D., Jojic, V., Sharma, S., Shen-Orr, S. S., Angel, C. J., Onengut-Gumuscu, S., et al. (2015). Cytomegalovirus infection enhances the immune response to influenza. Sci. Transl. Med. 7:281ra43. doi: 10.1126/scitranslmed.aaa2293
47. Furman, M. H., Dey, N., Tortorella, D., and Ploegh, H. L. (2002). The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J. Virol. 76, 11753-11756. doi: 10.1128/JVI.76.22.11753-11756.2002
48. Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., et al. (2017). Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 19, 1189-1201. doi: 10.1016/j.celrep.2017.04.031
49. Getts, D. R., Chastain, E. M. L., Terry, R. L., and Miller, S. D. (2013). Virus infection, antiviral immunity, and autoimmunity. Immunol. Rev. 255, 197-209. doi: 10.1111/imr.12091
50. Gimble, J. M., Duh, E., Ostrove, J. M., Gendelman, H. E., Max, E. E., and Rabson, A. B. (1988). Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence. J. Virol. 62, 4104-4112
51. Grauwet, K., Cantoni, C., Parodi, M., De Maria, A., Devriendt, B., Pende, D., et al. (2014). Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. Proc. Natl. Acad. Sci. U.S.A. 111, 16118-16123. doi: 10.1073/pnas.1409485111
52. Gredmark-Russ, S., Cheung, E. J., Isaacson, M. K., Ploegh, H. L., and Grotenbreg, G. M. (2008). The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J. Virol. 82, 12205-12212. doi: 10.1128/JVI.01463-08
53. Grey, F. (2015). Role of microRNAs in herpesvirus latency and persistence. J. Gen. Virol. 96, 739-751. doi: 10.1099/vir.0.070862-0
54. Grey, F., Meyers, H., White, E. A., Spector, D. H., and Nelson, J. (2007). A human cytomegalovirus-encoded microRNA Regulates expression of multiple viral genes involved in replication. PLoS Pathog. 3:e163. doi: 10.1371/journal.ppat.0030163
55. Grivel, J.-C., Ito, Y., Fagà, G., Santoro, F., Shaheen, F., Malnati, M. S., et al. (2001). Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat. Med. 7, 1232-1235. doi: 10.1038/nm1101-1232
56. Grogg, K. L., Miller, R. F., and Dogan, A. (2007). HIV infection and lymphoma. J. Clin. Pathol. 60, 1365-1372. doi: 10.1136/jcp.2007.051953
57. Halenius, A., Gerke, C., and Hengel, H. (2015). Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets-but how many arrows in the quiver? Cell. Mol. Immunol. 12, 139-153. doi: 10.1038/cmi.2014.105
58. Haque, A., Rachinel, N., Quddus, M. R., Haque, S., Kasper, L. H., and Usherwood, E. (2004). Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clin. Exp. Immunol. 138, 396-404. doi: 10.1111/j.1365-2249.2004.02652.x
59. He, B., Gross, M., and Roizman, B. (1997). The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoffof protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 94, 843-848. doi: 10.1073/pnas.94.3.843
60. Heiden, D., Ford, N., Wilson, D., Rodriguez, W. R., Margolis, T., Janssens, B., et al. (2007). Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med. 4:e334. doi: 10.1371/journal.pmed.0040334
61. Henderson, G., Peng, W., Jin, L., Perng, G.-C., Nesburn, A., Wechsler, S., et al. (2002). Regulation of caspase 8-and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript. J. Neurovirol. 8, 103-111. doi: 10.1080/13550280290101085
62. Hengel, H., Koopmann, J. O., Flohr, T., Muranyi, W., Goulmy, E., Hämmerling, G. J., et al. (1997). A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6, 623-632. doi: 10.1016/S1074-7613(00)80350-7
63. Hewitt, E. W. (2003). The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110, 163-169. doi: 10.1046/j.1365-2567.2003.01738.x
64. Hill, A., Jugovic, P., York, lan, Russ, G., Bennink, J., Yewdell, J., et al. (1995). Herpes simplex virus turns offthe TAP to evade host immunity. Nature 375, 411-415. doi: 10.1038/375411a0
65. Hsieh, S.-T., Lin, W.-M., Chiang, H.-Y., Huang, I.-T., Ko, M.-H., Chang, Y.-C., et al. (1997). Skin innervation and its effects on the epidermis. J. Biomed. Sci. 4, 264-268. doi: 10.1007/BF02253428
66. Huck, K., Feyen, O., Niehues, T., Rüschendorf, F., Hübner, N., Laws, H.-J., et al. (2009). Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J. Clin. Invest. 119, 1350-1358. doi: 10.1172/JCI37901
67. Husain, S. M., Usherwood, E. J., Dyson, H., Coleclough, C., Coppola, M. A., Woodland, D. L., et al. (1999). Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc. Natl. Acad. Sci. USA. 96, 7508-7513. doi: 10.1073/pnas.96.13.7508
68. Ishido, S., Choi, J. K., Lee, B. S., Wang, C., DeMaria, M., Johnson, R. P., et al. (2000). Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13, 365-374. doi: 10.1016/S1074-7613(00)00036-4
69. Iskra, S., Kalla, M., Delecluse, H.-J., Hammerschmidt, W., and Moosmann, A. (2010). Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus. J. Virol. 84, 3612-3623. doi: 10.1128/JVI.01400-09
70. Iwasaki, A. (2012). A virological view of innate immune recognition. Annu. Rev. Microbiol. 66, 177-196. doi: 10.1146/annurev-micro-092611-150203
71. Jones, T. R., and Sun, L. (1997). Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71, 2970-2979
72. Jonjic, S., Babic, M., Polic, B., and Krmpotic, A. (2008). Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20, 30-38. doi: 10.1016/j.coi.2007.11.002
73. Jost, S., and Altfeld, M. (2013). Control of human viral infections by natural killer cells. Annu. Rev. Immunol. 31, 163-194. doi: 10.1146/annurev-immunol-032712-100001
74. Kägi, D., Ledermann, B., Bürki, K., Zinkernagel, R. M., and Hengartner, H. (1996). Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232. doi: 10.1146/annurev.immunol.14.1.207
75. Kapadia, S. B., Levine, B., Speck, S. H., and Virgin, H. W. (2002). Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-Herpesvirus Infection. Immunity 17, 143-155. doi: 10.1016/S1074-7613(02)00369-2
76. Kelly, G. L., Milner, A. E., Baldwin, G. S., Bell, A. I., and Rickinson, A. B. (2006). Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 103, 14935-14940. doi: 10.1073/pnas.0509988103
77. Khairallah, C., Déchanet-Merville, J., and Capone, M. (2017). γδ T cell-mediated immunity to cytomegalovirus infection. Front. Immunol. 8:105. doi: 10.3389/fimmu.2017.00105
78. Khairallah, C., Netzer, S., Villacreces, A., Juzan, M., Rousseau, B., Dulanto, S., et al. (2015). γδ T cells confer protection against murine cytomegalovirus (MCMV). PLoS Pathog. 11:e1004702. doi: 10.1371/journal.ppat.1004702
79. Klein, G., Rotbard, J., Gotch, F. M., Bahadur, G., Wraith, D., McMichael, A. J., et al. (1989). Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58, 5-8. doi: 10.1016/0092-8674(89)90394-2
80. Knickelbein, J. E., Khanna, K. M., Yee, M. B., Baty, C. J., Kinchington, P. R., and Hendricks, R. L. (2008). Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322, 268-271. doi: 10.1126/science.1164164
81. Knipe, D. M., and Cliffe, A. (2008). Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Microbiol. 6, 211-221. doi: 10.1038/nrmicro1794
82. Koelle, D. M., and Corey, L. (2003). Recent progress in herpes simplex virus immunobiology and vaccine research. Clin. Microbiol. Rev. 16, 96-113. doi: 10.1128/CMR.16.1.96-113.2003
83. Kramer, M. F., and Coen, D. M. (1995). Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69, 1389-1399
84. Kriesel, J. D., Jones, B. B., Matsunami, N., Patel, M. K., St Pierre, C. A., Kurt-Jones, E. A., et al. (2011). C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene. J. Infect. Dis. 204, 1654-1662. doi: 10.1093/infdis/jir633
85. Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., and Colonna, M. (2004). Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103, 1433-1437. doi: 10.1182/blood-2003-08-2674
86. Kucera, L. S., Leake, E., Iyer, N., Raben, D., and Myrvik, Q. N. (1990). Human Immunodeficiency Virus Type 1 (HIV-1) and Herpes Simplex Virus Type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication. AIDS Res. Hum. Retroviruses 6, 641-647. doi: 10.1089/aid.1990.6.641
87. Laskey, A. L., Johnson, T. R., Dagartzikas, M. I., and Tobias, J. D. (2000). Endocarditis attributable to group A beta-hemolytic streptococcus after uncomplicated varicella in a vaccinated child. Pediatrics 106:E40. doi: 10.1542/peds.106.3.e40
88. Laupland, K. B., Davies, H. D., Low, D. E., Schwartz, B., Green, K., and McGeer, A. (2000). Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 105:E60. doi: 10.1542/peds.105.5.e60
89. Lecellier, C.-H., Dunoyer, P., Arar, K., Lehmann-Che, J., Eyquem, S., Himber, C., et al. (2005). A cellular microRNA mediates antiviral defense in human cells. Science 308, 557-560. doi: 10.1126/science.1108784
90. Leib, D. A., Bogard, C. L., Kosz-Vnenchak, M., Hicks, K. A., Coen, D. M., Knipe, D. M., et al. (1989). A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63, 2893-2900
91. Leppard, B., and Naburi, A. E. (1998). Herpes zoster: an early manifestation of HIV infection. Afr. Health 21, 5-6
92. Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A., and Masucci, M. G. (1997). Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. U.S.A. 94, 12616-12621. doi: 10.1073/pnas.94.23.12616
93. Li, F.-Y., Chaigne-Delalande, B., Kanellopoulou, C., Davis, J. C., Matthews, H. F., Douek, D. C., et al. (2011). Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475, 471-476. doi: 10.1038/nature10246
94. Lichtner, M., Cicconi, P., Vita, S., Cozzi-Lepri, A., Galli, M., Lo Caputo, S., et al. (2015). Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J. Infect. Dis. 211, 178-186. doi: 10.1093/infdis/jiu417
95. Linka, R. M., Risse, S. L., Bienemann, K., Werner, M., Linka, Y., Krux, F., et al. (2012). Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia 26, 963-971. doi: 10.1038/leu.2011.371
96. Litjens, N. H. R., van der Wagen, L., Kuball, J., and Kwekkeboom, J. (2018). Potential Beneficial effects of cytomegalovirus infection after transplantation. Front. Immunol. 9:389. doi: 10.3389/fimmu.2018.00389
97. Liu, T., Khanna, K. M., Carriere, B. N., and Hendricks, R. L. (2001). Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75, 11178-11184. doi: 10.1128/JVI.75.22.11178-11184.2001
98. Liu, T., Khanna, K. M., Chen, X., Fink, D. J., and Hendricks, R. L. (2000). CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191, 1459-1466. doi: 10.1084/jem.191.9.1459
99. Looker, K. J., Elmes, J. A. R., Gottlieb, S. L., Schiffer, J. T., Vickerman, P., Turner, K. M. E., et al. (2017). Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect. Dis. 17, 1303-1316. doi: 10.1016/S1473-3099(17)30405-X
100. Lubinski, J. M., Lazear, H. M., Awasthi, S., Wang, F., and Friedman, H. M. (2011). The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo. J. Virol. 85, 3239-3249. doi: 10.1128/JVI.02509-10
101. Lubinski, J. M., Wang, L., Soulika, A. M., Burger, R., Wetsel, R. A., Colten, H., et al. (1998). Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J. Virol. 72, 8257-8263
102. Lund, J. M., Hsing, L., Pham, T. T., and Rudensky, A. Y. (2008). Coordination of early protective immunity to viral infection by regulatory T cells. Science 320, 1220-1224. doi: 10.1126/science.1155209
103. Lünemann, J. D., Jelcic, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martin, R., et al. (2008). EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J. Exp. Med. 205, 1763-1773. doi: 10.1084/jem.20072397
104. Lünemann, J. D., Kamradt, T., Martin, R., and Münz, C. (2007). Epstein-barr virus: environmental trigger of multiple sclerosis? J. Virol. 81, 6777-6784. doi: 10.1128/JVI.00153-07
105. Maehlen, J., Olsson, T., Zachau, A., Klareskog, L., and Kristensson, K. (1989). Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons. J. Neuroimmunol. 23, 125-132. doi: 10.1016/0165-5728(89)90031-3
106. Margolis, D. M., Rabson, A. B., Straus, S. E., and Ostrove, J. M. (1992). Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Virology 186, 788-791. doi: 10.1016/0042-6822(92)90048-T
107. Mark, K. E., Wald, A., Magaret, A. S., Selke, S., Olin, L., Huang, M., et al. (2008). Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J. Infect. Dis. 198, 1141-1149. doi: 10.1086/591913
108. Marsh, R. A., and Filipovich, A. H. (2011). Familial hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease. Ann. N. Y. Acad. Sci. 1238, 106-121. doi: 10.1111/j.1749-6632.2011.06265.x
109. Matar, C. G., Anthony, N. R., O'Flaherty, B. M., Jacobs, N. T., Priyamvada, L., Engwerda, C. R., et al. (2015). Gammaherpesvirus co-infection with malaria suppresses anti-parasitic humoral immunity. PLoS Pathog. 11:e1004858. doi: 10.1371/journal.ppat.1004858
110. McClain, M. T., Rapp, E. C., Harley, J. B., and James, J. A. (2003). Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J. Med. Virol. 70, 253-257. doi: 10.1002/jmv.10385
111. McGeoch, D. J., Cook, S., Dolan, A., Jamieson, F. E., and Telford, E. A. R. (1995). Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 247, 443-458. doi: 10.1006/jmbi.1995.0152
112. McIntosh, M., Hauschild, B., and Miller, V. (2016). Human cytomegalovirus and transplantation: drug development and regulatory issues. J. virus Erad. 2, 143-148
113. McKeating, J. A., Griffiths, P. D., and Weiss, R. A. (1990). HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 343, 659-661. doi: 10.1038/343659a0
114. Medina, T. S., Costa, S. P. T., Oliveira, M. D., Ventura, A. M., Souza, J. M., Gomes, T. F., et al. (2011). Increased interleukin-10 and interferon-γ levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Malar. J. 10:264. doi: 10.1186/1475-2875-10-264
115. Moore, P. S., and Chang, Y. (2003). Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu. Rev. Microbiol. 57, 609-639. doi: 10.1146/annurev.micro.57.030502.090824
116. Moshous, D., Martin, E., Carpentier, W., Lim, A., Callebaut, I., Canioni, D., et al. (2013). Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation. J. Allergy Clin. Immunol. 131, 1594.e9-1603.e9. doi: 10.1016/j.jaci.2013.01.042
117. Münz, C., Lünemann, J. D., Getts, M. T., and Miller, S. D. (2009). Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9, 246-258. doi: 10.1038/nri2527
118. Münz, C., and Moormann, A. (2008). Immune escape by Epstein-Barr virus associated malignancies. Semin. Cancer Biol. 18, 381-387. doi: 10.1016/j.semcancer.2008.10.002
119. Nash, A. A., and Dutia, B. M. (2008). "Murine Gammaherpesvirus 68," in Encyclopedia of Virology, eds B. W. J. Mahy and M. H. V. van Regenmortel (Elsevier), 372-378
120. Nehme, N. T., Schmid, J. P., Debeurme, F., Andre-Schmutz, I., Lim, A., Nitschke, P., et al. (2012). MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 119, 3458-3468. doi: 10.1182/blood-2011-09-378364
121. Nicoll, M. P., Proença, J. T., and Efstathiou, S. (2012). The molecular basis of herpes simplex virus latency. FEMS Microbiol. Rev. 36, 684-705. doi: 10.1111/j.1574-6976.2011.00320.x
122. Odeberg, J., Plachter, B., Brandén, L., and Söderberg-Nauclér, C. (2003). Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR-chain. Blood 101, 4870-4877. doi: 10.1182/blood-2002-05-1504
123. Okoye, A. A., and Picker, L. J. (2013). CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol. Rev. 254, 54-64. doi: 10.1111/imr.12066
124. Openshaw, H., McNeill, J. I., Lin, X. H., Niland, J., and Cantin, E. M. (1995). Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J. Med. Virol. 46, 4675-4680. doi: 10.1002/jmv.1890460116
125. Orange, J. S., Fassett, M. S., Koopman, L. A., Boyson, J. E., and Strominger, J. L. (2002). Viral evasion of natural killer cells. Nat. Immunol. 3, 1006-1012. doi: 10.1038/ni1102-1006
126. Ostrove, J. M., Leonard, J., Weck, K. E., Rabson, A. B., and Gendelman, H. E. (1987). Activation of the human immunodeficiency virus by herpes simplex virus type 1. J. Virol. 61, 3726-3732
127. Ouwendijk, W. J. D., Choe, A., Nagel, M. A., Gilden, D., Osterhaus, A. D. M. E., Cohrs, R. J., et al. (2012). Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J. Virol. 86, 10203-10206. doi: 10.1128/JVI.01331-12
128. Oyake, S., Ohi, T., and Koga, M. (2000). A case of varicella complicated by cellulitis and scarlet fever due to Streptococcus pyogenes. J. Dermatol. 27, 750-752. doi: 10.1111/j.1346-8138.2000.tb02272.x
129. Pan, D., Flores, O., Umbach, J. L., Pesola, J. M., Bentley, P., Rosato, P. C., et al. (2014). A neuron-specific host microrna targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe 15, 446-456. doi: 10.1016/j.chom.2014.03.004
130. Parrish, C. R., Holmes, E. C., Morens, D. M., Park, E.-C., Burke, D. S., Calisher, C. H., et al. (2008). Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 72, 457-470. doi: 10.1128/MMBR.00004-08
131. Parvaneh, N., Filipovich, A. H., and Borkhardt, A. (2013). Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases. Br. J. Haematol. 162, 573-586. doi: 10.1111/bjh.12422
132. Peng, T., Zhu, J., Klock, A., Phasouk, K., Huang, M.-L., Koelle, D. M., et al. (2009). Evasion of the mucosal innate immune system by herpes simplex virus type 2. J. Virol. 83, 12559-12568. doi: 10.1128/JVI.00939-09
133. Perkins, D., Pereira, E. F. R., Gober, M., Yarowsky, P. J., and Aurelian, L. (2002). The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 76, 1435-1449. doi: 10.1128/JVI.76.3.1435-1449.2002
134. Perng, G. C., Jones, C., Ciacci-Zanella, J., Stone, M., Henderson, G., Yukht, A., et al. (2000). Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287, 1500-1503. doi: 10.1126/science.287.5457.1500
135. Peyron, F., Burdin, N., Ringwald, P., Vuillez, J. P., Rousset, F., and Banchereau, J. (1994). High levels of circulating IL-10 in human malaria. Clin. Exp. Immunol. 95, 300-303. doi: 10.1111/j.1365-2249.1994.tb06527.x
136. Ploegh, H. L. (1998). Viral strategies of immune evasion. Science 280, 248-253. doi: 10.1126/science.280.5361.248
137. Poole, B. D., Scofield, R. H., Harley, J. B., and James, J. A. (2006). Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39, 63-70. doi: 10.1080/08916930500484849
138. Poppers, J., Mulvey, M., Khoo, D., and Mohr, I. (2000). Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J. Virol. 74, 11215-21. doi: 10.1128/JVI.74.23.11215-11221.2000
139. Rafailidis, P. I., Mourtzoukou, E. G., Varbobitis, I. C., and Falagas, M. E. (2008). Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol. J. 5, 47. doi: 10.1186/1743-422X-5-47
140. Reddy, P. B. J., Sehrawat, S., Suryawanshi, A., Rajasagi, N. K., Mulik, S., Hirashima, M., et al. (2011). Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J. Immunol. 187, 5745-5755. doi: 10.4049/jimmunol.1102105
141. Regezi, J. A., Eversole, L. R., Barker, B. F., Rick, G. M., and Silverman, S. (1996). Herpes simplex and cytomegalovirus coinfected oral ulcers in HIV-positive patients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 81, 55-62. doi: 10.1016/S1079-2104(96)80149-1
142. Remeijer, L., Maertzdorf, J., Doornenbal, P., Verjans, G. M., and Osterhaus, A. D. (2001). Herpes simplex virus 1 transmission through corneal transplantation. Lancet 357:442. doi: 10.1016/S0140-6736(00)04011-3
143. Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Gomez, R., Heemskerk, B., Toebes, M., et al. (2003). Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc. Natl. Acad. Sci. U.S.A. 100, 11583-11588. doi: 10.1073/pnas.2034960100
144. Rezaee, S. A. R., Cunningham, C., Davison, A. J., and Blackbourn, D. J. (2006). Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J. Gen. Virol. 87, 1781-1804. doi: 10.1099/vir.0.81919-0
145. Richman, L. K., Montali, R. J., Cambre, R. C., Schmitt, D., Hardy, D., Hildbrandt, T., et al. (2000). Clinical and pathological findings of a newly recognized disease of elephants caused by endotheliotropic herpesviruses. J. Wildl. Dis. 36, 1-12. doi: 10.7589/0090-3558-36.1.1
146. Richman, L. K., Montali, R. J., Garber, R. L., Kennedy, M. A., Lehnhardt, J., Hildebrandt, T., et al. (1999). Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science 283, 1171-1176. doi: 10.1126/science.283.5405.1171
147. Robinson, C. M., and Pfeiffer, J. K. (2014). Viruses and the Microbiota. Annu. Rev. Virol. 1, 55-69. doi: 10.1146/annurev-virology-031413-085550
148. Roizman, B., and Whitley, R. J. (2013). An inquiry into the molecular basis of HSV latency and reactivation. Annu. Rev. Microbiol. 67, 355-374. doi: 10.1146/annurev-micro-092412-155654
149. Rosato, P. C., Leib, D. A., Saun, M., van, Ying, G.-S., Oh, J., and Fraser, N. (2015). neuronal interferon signaling is required for protection against herpes simplex virus replication and pathogenesis. PLoS Pathog. 11:e1005028. doi: 10.1371/journal.ppat.1005028
150. Rouse, B. T., and Sehrawat, S. (2010). Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 10, 514-526. doi: 10.1038/nri2802
151. Rowe, M., Glaunsinger, B., van Leeuwen, D., Zuo, J., Sweetman, D., Ganem, D., et al. (2007). Host shutoffduring productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc. Natl. Acad. Sci. U.S.A. 104, 3366-3371. doi: 10.1073/pnas.0611128104
152. Ru, J., Sun, H., Fan, H., Wang, C., Li, Y., Liu, M., et al. (2014). MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1. PLoS ONE 9:e114021. doi: 10.1371/journal.pone.0114021
153. Ruffner, M. A., Sullivan, K. E., and Henrickson, S. E. (2017). Recurrent and sustained viral infections in primary immunodeficiencies. Front. Immunol. 8:665. doi: 10.3389/fimmu.2017.00665
154. Safdar, A., Rubocki, R. J., Horvath, J. A., Narayan, K. K., and Waldron, R. L. (2002). Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin. Infect. Dis. 35, 1250-1257. doi: 10.1086/344056
155. Salzberger, B., Hartmann, P., Hanses, F., Uyanik, B., Cornely, O. A., Wöhrmann, A., et al. (2005). Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection 33, 345-349. doi: 10.1007/s15010-005-5050-z
156. Salzer, E., Daschkey, S., Choo, S., Gombert, M., Santos-Valente, E., Ginzel, S., et al. (2013). Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 98, 473-478. doi: 10.3324/haematol.2012.068791
157. Sarangi, P. P., Sehrawat, S., Suvas, S., and Rouse, B. T. (2008). IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J. Immunol. 180, 6297-6306. doi: 10.4049/jimmunol.180.9.6297
158. Sawtell, N. M., and Thompson, R. L. (2016). De novo herpes simplex virus VP16 expression gates a dynamic programmatic transition and sets the latent/lytic balance during acute infection in trigeminal ganglia. PLoS Pathog. 12:e1005877. doi: 10.1371/journal.ppat.1005877
159. Sedarati, F., and Stevens, J. G. (1987). Biological basis for virulence of three strains of herpes simplex virus type 1. J. Gen. Virol. 68, 2389-2395. doi: 10.1099/0022-1317-68-9-2389
160. Sehrawat, S., Kirak, O., Koenig, P.-A., Isaacson, M. K., Marques, S., Bozkurt, G., et al. (2012). CD8+ T cells from mice transnuclear for a TCR that recognizes a single H-2Kb-restricted MHV68 epitope derived from gB-ORF8 help control infection. Cell Rep. 1, 461-471. doi: 10.1016/j.celrep.2012.03.009
161. Sehrawat, S., and Rouse, B. T. (2017). Interplay of regulatory T cell and Th17 cells during infectious diseases in humans and animals. Front. Immunol. 8:341. doi: 10.3389/fimmu.2017.00341
162. Sepkowitz, K. A. (2001). AIDS-the first 20 years. N. Engl. J. Med. 344, 1764-1772. doi: 10.1056/NEJM200106073442306
163. Shannon, B., Gajer, P., Yi, T. J., Ma, B., Humphrys, M. S., Thomas-Pavanel, J., et al. (2017). Distinct effects of the cervicovaginal microbiota and herpes simplex type 2 infection on female genital tract immunology. J. Infect. Dis. 215, 1366-1375. doi: 10.1093/infdis/jix088
164. Simmons, A., Slobedman, B., Speck, P., Arthur, J., and Efstathiou, S. (1992). Two patterns of persistence of herpes simplex virus DNA sequences in the nervous systems of latently infected mice. J. Gen. Virol. 73, 1287-1291. doi: 10.1099/0022-1317-73-5-1287
165. Sinclair, J., and Sissons, P. (2006). Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87, 1763-1779. doi: 10.1099/vir.0.81891-0
166. Slobedman, B., and Mocarski, E. S. (1999). Quantitative analysis of latent human cytomegalovirus. J. Virol. 73, 4806-4812
167. Smith, H. R. C., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V, et al. (2002). Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. U.S.A. 99, 8826-8831. doi: 10.1073/pnas.092258599
168. Smith, T. J., Morrison, L. A., and Leib, D. A. (2002). Pathogenesis of herpes simplex virus type 2 virion host shutoff(VHS) mutants. J. Virol. 76, 2054-2061. doi: 10.1128/jvi.76.5.2054-2061.2002
169. Speck, S. H., and Ganem, D. (2010). Viral latency and its regulation: lessons from the γ-herpesviruses. Cell Host Microbe 8, 100-115. doi: 10.1016/j.chom.2010.06.014
170. Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. T., et al. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76, 1285-1292. doi: 10.1128/JVI.76.3.1285-1292.2002
171. Steed, A. L., Barton, E. S., Tibbetts, S. A., Popkin, D. L., Lutzke, M. L., Rochford, R., et al. (2006). Gamma interferon blocks gammaherpesvirus reactivation from latency. J. Virol. 80, 192-200. doi: 10.1128/JVI.80.1.192-200.2006
172. Steffens, H. P., Kurz, S., Holtappels, R., and Reddehase, M. J. (1998). Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J. Virol. 72, 1797-1804
173. Stepensky, P., Weintraub, M., Yanir, A., Revel-Vilk, S., Krux, F., Huck, K., et al. (2011). IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica 96, 472-476. doi: 10.3324/haematol.2010.033910
174. Stevens, J. G. (1989). Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53, 318-332
175. Strelow, L. I., and Leib, D. A. (1995). Role of the virion host shutoff(vhs) of herpes simplex virus type 1 in latency and pathogenesis. J. Virol. 69, 6779-6786
176. Sun, J. C., Beilke, J. N., and Lanier, L. L. (2009). Adaptive immune features of natural killer cells. Nature 457, 557-561. doi: 10.1038/nature07665
177. Suvas, S., Azkur, A. K., and Rouse, B. T. (2006). Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J. Immunol. 176, 1703-1711. doi: 10.4049/jimmunol.176.3.1703
178. Takeda, A., Tuazon, C. U., and Ennis, F. A. (1988). Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242, 580-583. doi: 10.1126/science.2972065
179. Takeuchi, O., and Akira, S. (2009). Innate immunity to virus infection. Immunol. Rev. 227, 75-86. doi: 10.1111/j.1600-065X.2008.00737.x
180. Tobian, A. A., and Quinn, T. C. (2009). Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Curr. Opin. HIV AIDS 4, 294-299. doi: 10.1097/COH.0b013e32832c1881
181. Tomazin, R., van Schoot, N. E., Goldsmith, K., Jugovic, P., Semp, é, P., Früh, K., et al. (1998). Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J. Virol. 72, 2560-2563
182. Tontodonati, M., Ursini, T., Polilli, E., Vadini, F., Di Masi, F., Volpone, D., et al. (2012). Post-herpetic neuralgia. Int. J. Gen. Med. 5, 861-871. doi: 10.2147/IJGM.S10371
183. Torgbor, C., Awuah, P., Deitsch, K., Kalantari, P., Duca, K. A., and Thorley-Lawson, D. A. (2014). A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis. PLoS Pathog. 10, e1004170. doi: 10.1371/journal.ppat.1004170
184. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., and Ploegh, H. L. (2000). Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926. doi: 10.1146/annurev.immunol.18.1.861
185. Treat, B. R., Bidula, S. M., Ramachandran, S., St Leger, A. J., Hendricks, R. L., and Kinchington, P. R. (2017). Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells. PLoS Pathog. 13:e1006732. doi: 10.1371/journal.ppat.1006732
186. Umbach, J. L., Kramer, M. F., Jurak, I., Karnowski, H. W., Coen, D. M., and Cullen, B. R. (2008). MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454, 780-783. doi: 10.1038/nature07103
187. Underdown, S. J., Kumar, K., and Houldcroft, C. (2017). Network analysis of the hominin origin of Herpes Simplex virus 2 from fossil data. Virus Evol. 3:vex026. doi: 10.1093/ve/vex026
188. Uppal, T., Banerjee, S., Sun, Z., Verma, S. C., and Robertson, E. S. (2014). KSHV LANA-the master regulator of KSHV latency. Viruses 6, 4961-4998. doi: 10.3390/v6124961
189. van Montfrans, J. M., Hoepelman, A. I. M., Otto, S., van Gijn, M., van de Corput, L., de Weger, R. A., et al. (2012). CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J. Allergy Clin. Immunol. 129, 787.e6-793.e6. doi: 10.1016/j.jaci.2011.11.013
190. Veiga-Parga, T., Sehrawat, S., and Rouse, B. T. (2013). Role of regulatory T cells during virus infection. Immunol. Rev. 255, 182-196. doi: 10.1111/imr.12085
191. Verweij, M. C., Ressing, M. E., Knetsch, W., Quinten, E., Halenius, A., van Bel, N., et al. (2011). Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses. Mol. Immunol. 48, 835-845. doi: 10.1016/j.molimm.2010.12.008
192. Virgin, H. W. (2014). The virome in mammalian physiology and disease. Cell 157, 142-150. doi: 10.1016/j.cell.2014.02.032
193. Virgin, H. W., Wherry, E. J., and Ahmed, R. (2009). Redefining chronic viral infection. Cell 138, 30-50. doi: 10.1016/j.cell.2009.06.036
194. Wald, A., and Corey, L. (2007). "Persistence in the population: epidemiology, transmission," in Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, eds A. Arvin, G. Campadelli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, R. Whitley, and K. Yamanishi (Cambridge: Cambridge University Press)
195. Wald, A., Zeh, J., Selke, S., Warren, T., Ashley, R., and Corey, L. (2002). Genital shedding of herpes simplex virus among men. J. Infect. Dis. 186, S34-S39. doi: 10.1086/342969
196. Welsh, R. M., Che, J. W., Brehm, M. A., and Selin, L. K. (2010). Heterologous immunity between viruses. Immunol. Rev. 235, 244-266. doi: 10.1111/j.0105-2896.2010.00897.x
197. Welsh, R. M., and Fujinami, R. S. (2007). Pathogenic epitopes, heterologous immunity and vaccine design. Nat. Rev. Microbiol. 5, 555-563. doi: 10.1038/nrmicro1709
198. Welsh, R. M., and Selin, L. K. (2002). No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2, 417-426. doi: 10.1038/nri820
199. Wertheim, J. O., Smith, M. D., Smith, D. M., Scheffler, K., and Kosakovsky Pond, S. L. (2014). Evolutionary origins of human herpes simplex viruses 1 and 2. Mol. Biol. Evol. 31, 2356-2364. doi: 10.1093/molbev/msu185
200. Westmoreland, D., and Watkins, J. F. (1974). The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG. J. Gen. Virol. 24, 167-178. doi: 10.1099/0022-1317-24-1-167
201. White, D. W., Keppel, C. R., Schneider, S. E., Reese, T. A., Coder, J., Payton, J. E., et al. (2010). Latent herpesvirus infection arms NK cells. Blood 115, 4377-4383. doi: 10.1182/blood-2009-09-245464
202. White, D. W., Suzanne Beard, R., and Barton, E. S. (2012). Immune modulation during latent herpesvirus infection. Immunol. Rev. 245, 189-208. doi: 10.1111/j.1600-065X.2011.01074.x
203. Whitley, R. J. (1996). Herpesviruses. University of Texas Medical Branch at Galveston
204. Wilcox, C. L., Smith, R. L., Freed, C. R., and Johnson, E. M. (1990). Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J. Neurosci. 10, 1268-1275. doi: 10.1523/JNEUROSCI.10-04-01268.1990
205. Wilson, A. C., and Mohr, I. (2012). A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol. 20, 604-611. doi: 10.1016/j.tim.2012.08.005
206. Wilson, G. J., Talkington, D. F., Gruber, W., Edwards, K., and Dermody, T. S. (1995). Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin. Infect. Dis. 20, 1333-8. doi: 10.1093/clinids/20.5.1333
207. Wozniakowski, G., and Samorek-Salamonowicz, E. (2015). Animal herpesviruses and their zoonotic potential for cross-species infection. Ann. Agric. Environ. Med. 22, 191-194. doi: 10.5604/12321966.1152063
208. Wucherpfennig, K. W., and Strominger, J. L. (1995). Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705. doi: 10.1016/0092-8674(95)90348-8
209. Zachariadou, L., Stathi, A., Tassios, P. T., Pangalis, A., Legakis, N. J., Papaparaskevas, J., et al. (2014). Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections. Epidemiol. Infect. 142, 512-519. doi: 10.1017/S0950268813001386
210. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., and Karin, M. (1997). The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91, 243-252. doi: 10.1016/S0092-8674(00)80406-7
211. Zeidler, R., Eissner, G., Meissner, P., Uebel, S., Tampé, R., Lazis, S., et al. (1997). Downregulation of TAP1 in B Lymphocytes by Cellular and Epstein-Barr Virus-Encoded Interleukin-10. Blood 90, 2390-2397
212. Zhang, S.-Y., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P., et al. (2007). TLR3 deficiency in patients with herpes simplex encephalitis. Sci. 317, 1522-1527. doi: 10.1126/science.1139522
213. Zhao, Z.-S., Granucci, F., Yeh, L., Schaffer, P. A., and Cantor, H. (1998). Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279. doi: 10.1126/science.279.5355.1344
214. Zheng, S., Li, Y., Zhang, Y., Li, X., and Tang, H. (2011). MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res. 89, 219-226. doi: 10.1016/j.antiviral.2011.01.008
215. Zhou, G., Galvan, V., Campadelli-Fiume, G., and Roizman, B. (2000). Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J. Virol. 74, 11782-11791. doi: 10.1128/JVI.74.24.11782-11791.2000
216. Zhu, J., Hladik, F., Woodward, A., Klock, A., Peng, T., Johnston, C., et al. (2009). Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15, 886-892. doi: 10.1038/nm.2006
217. Zuo, J., Quinn, L. L., Tamblyn, J., Thomas, W. A., Feederle, R., Delecluse, H.-J., et al. (2011a). The Epstein-barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. J. Virol. 85, 1604-1614. doi: 10.1128/JVI.01608-10
218. Zuo, J., Thomas, W. A., Haigh, T. A., Fitzsimmons, L., Long, H. M., Hislop, A. D., et al. (2011b). Epstein-barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2. PLoS Pathog. 7:e1002455. doi: 10.1371/journal.ppat.1002455